Abstract: The present invention relates to an aqueous composition which comprises chondroitin sulfate, hyaluronic acid, and a pharmaceutically acceptable carrier, and which can be stored at room temperature. The present invention also relates to an aqueous composition which comprises chondroitin sulfate, hyaluronic acid, sorbitol, and a pharmaceutical acceptable carrier.

Abstract: The present invention relates to an aqueous composition which comprises chondroitin sulfate, hyaluronic acid, and a pharmaceutically acceptable carrier, and which can be stored at room temperature. The present invention also relates to an aqueous composition which comprises chondroitin sulfate, hyaluronic acid, sorbitol, and a pharmaceutical acceptable carrier.

Abstract: The present invention relates to an aqueous composition which comprises chondroitin sulfate, hyaluronic acid, and a pharmaceutically acceptable carrier, and which can be stored at room temperature. The present invention also relates to an aqueous composition which comprises chondroitin sulfate, hyaluronic acid, sorbitol, and a pharmaceutical acceptable carrier.

Abstract: With an object of providing an orally administered agent (in particular a film-shaped orally administered agent) with which the ease and safety of taking the agent are improved, to attain this object, in an orally administered agent 1b having one drug-containing layer 11 and two water-swellable gel-forming layers 12, the water-swellable gel-forming layers 12 are provided, either directly or via intermediate layers, on the both faces of the drug-containing layer 11.

Abstract: With an object of providing an orally administered agent (in particular a film-shaped orally administered agent) with which the ease and safety of taking the agent are improved, to attain this object, in an orally administered agent 1b having one drug-containing layer 11 and two water-swellable gel-forming layers 12, the water-swellable gel-forming layers 12 are provided, either directly or via intermediate layers, on the both faces of the drug-containing layer 11.

Abstract: With an object of providing an orally administered agent (in particular a film-shaped orally administered agent) with which the ease and safety of taking the agent are improved, to attain this object, in an orally administered agent 1b having one drug-containing layer 11 and two water-swellable gel-forming layers 12, the water-swellable gel-forming layers 12 are provided, either directly or via intermediate layers, on the both faces of the drug-containing layer 11.

Abstract: With an object of providing an orally administered agent (in particular a film-shaped orally administered agent) with which the ease and safety of taking the agent are improved, to attain this object, in an orally administered agent 1b having one drug-containing layer 11 and two water-swellable gel-forming layers 12, the water-swellable gel-forming layers 12 are provided, either directly or via intermediate layers, on the both faces of the drug-containing layer 11.

Abstract: With the object of providing a method for producing a pharmaceutical composition comprising a drug-containing layer, a first functional layer provided to one side of the drug-containing layer either directly or via an intermediate layer, and a second functional layer provided to the other side of the drug-containing layer either directly or via an intermediate layer, wherein the time during which the drug is heated is minimized and the number of steps required to produce the pharmaceutical composition is also minimized, a first intermediate 11a is prepared comprising a first drug-containing layer 3a containing a thermoplastic polymer as a base as well as a first functional layer 2a provided to one side of the first drug-containing layer 3a, with the other side of the first drug-containing layer 3a being exposed, and a second intermediate 11b is prepared comprising a second drug-containing layer 3b containing a thermoplastic polymer as a base as well as a second functional layer 2b provided to one side of the

Abstract: An object of the present invention is to provide an orally administered pharmaceutical composition comprising a drug-containing layer and a functional layer wherein cracks and gaps in the drug-containing layer are prevented even if the amount of glycerin contained in the drug-containing layer is not sufficient to cause bleeding of the drug-containing layer at the edges of the orally administered pharmaceutical composition, and to achieve the object, polyvinylpyrrolidone with a K value of 70 or more is contained as a base in the drug-containing layer.

Abstract: It is an object of the present invention to provide an orally administered pharmaceutical composition capable of completely masking the flavor, odor and the like of a drug contained in a drug-containing layer, and to achieve this object, the outer edge of a first water-swellable gel-forming layer 12a and the outer edge of a second water-swellable gel-forming layer 12? are bonded together so as to enclose a drug-containing layer 11 inside an orally administered pharmaceutical composition 1a in the orally administered pharmaceutical composition 1a comprising the first water-swellable gel-forming layer 12a and the second water-swellable gel-forming layer 12? in the outermost layer.

Abstract: A number of embodiments of air cooled compact power supplies having air inlet and air outlet openings in the lower portion of the housing of the power supply. The interior of the power supply is baffled so that the air flowing through it must follow a serpentine path to prevent air entrained foreign materials from impinging upon the engine.